Capacity at Blu Pharmaceutical’s recently acquired solid dosage production plant in Puerto Rico is set to expand considerable over the next three years according to company president Bill Luster.
eBizNET has entered into a strategic relationship with CDC Software, which is expected to accelerate the deployment of its SaaS supply chain systems in emerging, high growth markets.
Demand in “Pharmerging” markets will offset declining revenues from off-patent blockbusters and drive prescription drug sales to $1.1tr (€819bn) by 2014, according to IMS Health.
PRA has expanded into New Zealand, complementing its Asia-Pacific network and establishing a point of contact for pharmas interested in benefiting from the county’s high recruitment rates.
Charles River Laboratories’ (CRL) Shanghai preclinical test facility GLP certified by Belgian authorities under the OECD’s mutual acceptance of data framework.
IT giant Oracle will pay $685m (€507m) for eClinical solutions firm Phase Forward, significantly expanding its presence in the billion dollar contract clinical research sector.
The EFPIA has hailed its 2-D data matrix anti-counterfeiting pilot scheme as a success and hopes to convince governments and supply chain actors of benefits of the approach.
in-PharmaTechnologist presents exclusive interactive maps of pharma manufacturing facilities in India, detailing the number of bulk drug and formulation facilities in each region of the country.
The US Food and Drug Administration (FDA) has issued Apotex with another warning letter about cGMP violations at two plants explaining the firm’s response to previous warnings “is inadequate and lacks sufficient corrective actions.”
“Good business development” in the pharma and “slow spending” in the cyclical cosmetics and life sciences sectors dominated Gerreshimer’s performance in the first quarter of 2010.
Hong Kong, China-based drug wholesaler Julius Chen & Co has been ordered to recall 300mg/tablet formulation of a gout treatment name Puricos (allopurinol) after DoH officials discovered the firm packaged it without a license to do so.
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.
Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar.
US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.
Aris Global has introduced Total Clinical 2.0, a software package which integrates EDC, safety and adverse event systems to streamline operations and cut costs.
US biotechnology company Genentech presents new $400m pharmaceutical manufacturing and distribution facility in Hillsboro, Oregon and says construction is nearly complete.
Chiltern has invested in endpoint to establish a strategic relationship which allows it to offer an IRT capable of cutting timelines and costs, a company EVP told Outsourcing-Pharma.
Contract research organisation (CRO) Ricerca Biosciences has entered into a business development deal with Japan-based Life Science Partner (LSP) to help penetrate the Asian market.
Almac has launched an online tool that allows trial sponsors to view, trace and amend trial material labels from anywhere in the world which, it claims, will improve and accelerate the approval process.
Sanofi-Aventis says French manufacturing operations will focus on vaccine and biotech drugs, unveiling €150m ($202m) plan to shift emphasis away from synthetic chemistry-based production.
Hyde Engineering + Consulting has opened an office in Dublin, Ireland, enhancing its ability to provide Europe-based biopharm with compliance, qualification and automation services.
A new nano-based coating that is claimed to reduce packaging waste is initially being targeted at the pharmaceutical sector but could be used in chocolate packaging as well, claims the VTT Technical Research Centre of Finland
The Klockner Pentaplast Group has invested $37m (€27m) to expand PVC production capacity and add shrink-label film capabilities at its facilities in Thailand and the US.
The FDA’s draft guidance on adaptive design in clinical trials is a balanced, practical publication, according to the EVP of a CRO who expects the document to generate a “robust discussion”.
The market for “nano-enabled” pharmaceutical packaging is growing 16.5 per cent a year and will be worth $8.1bn (€6bn) by 2014 according to new research by iRAP.
The WHO has published its views on the production of starting materials in draft guidance which details recommendations to ensure product quality while keeping costs down.
The European Medicines Agency (EMA) has recommended a recall of Acino’s generic Plavix (clopidogrel bisulfate) because of alleged failings in GMP at the API production facility.
Thermo Fisher Scientific will take charge of clinical trial material production at Eli Lilly’s research technology facility in Indianapolis as the pharmaceutical firm further reduces in-house capacity to cut costs.
The UK budget was “a missed opportunity” to encourage manufacturing, according to UK Chemical Industries Association (CIA), but was free from unexpected tax increases.
Clinical trials that finish early due to positive treatment effects often have misleading findings, according to a journal paper which recommends researchers resist pressures to end studies prematurely.
Contract manufacturing organization (CMO) ScinoPharm says strong anticancer API sales and growing demand in Europe and Asia were key to record performance in 2009.
PPD has added capabilities at the facility acquired from Merck & Co and improved integration of other sites to create its Vaccines & Biologics Center of Excellence, a single provider of multiple laboratory services.
Liquent and Take Solutions say their new partnership provides pharmaceutical firms with an efficient, cost effective outsourced solution for regulatory publication and submissions.
The increasing incidence of chronic and “lifestyle” related disorders will fuel demand for inhalable delivery technologies over the next five years, according to a Global Industry Analysts (GIA) report.
The IPEA's issuance of good manufacturing practice (GMP) “certification” is mark of manufacturing quality, says US specialty chemicals supplier W R Grace & Co.
